Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Go back to Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 59.92 -4.04 (6.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.96 | 52 Week High | $0.52 | |||
| Open | $64.07 | 52 Week Low | $0.08 | |||
| Day High | $65.51 | P/E | N/A | |||
| Day Low | $57.50 | EPS | $-3.80 | |||
| Volume | 4,258,882 | |||||
